Logo image of NGVT

INGEVITY CORP (NGVT) Stock Fundamental Analysis

NYSE:NGVT - New York Stock Exchange, Inc. - US45688C1071 - Common Stock - Currency: USD

41.19  +0.13 (+0.32%)

Fundamental Rating

4

Overall NGVT gets a fundamental rating of 4 out of 10. We evaluated NGVT against 85 industry peers in the Chemicals industry. Both the profitability and the financial health of NGVT get a neutral evaluation. Nothing too spectacular is happening here. A decent growth rate in combination with a cheap valuation! Better keep an eye on NGVT.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year NGVT was profitable.
NGVT had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: NGVT reported negative net income in multiple years.
Each year in the past 5 years NGVT had a positive operating cash flow.
NGVT Yearly Net Income VS EBIT VS OCF VS FCFNGVT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

NGVT has a worse Return On Assets (-17.21%) than 83.53% of its industry peers.
NGVT has a worse Return On Equity (-150.81%) than 92.94% of its industry peers.
NGVT has a better Return On Invested Capital (12.56%) than 91.76% of its industry peers.
The Average Return On Invested Capital over the past 3 years for NGVT is above the industry average of 7.01%.
The last Return On Invested Capital (12.56%) for NGVT is above the 3 year average (10.65%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -17.21%
ROE -150.81%
ROIC 12.56%
ROA(3y)-4.58%
ROA(5y)-0.24%
ROE(3y)-63.66%
ROE(5y)-29.04%
ROIC(3y)10.65%
ROIC(5y)10.84%
NGVT Yearly ROA, ROE, ROICNGVT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

NGVT's Operating Margin of 21.09% is amongst the best of the industry. NGVT outperforms 88.24% of its industry peers.
NGVT's Operating Margin has declined in the last couple of years.
The Gross Margin of NGVT (34.69%) is better than 70.59% of its industry peers.
NGVT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 21.09%
PM (TTM) N/A
GM 34.69%
OM growth 3Y-6.17%
OM growth 5Y-4.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.27%
GM growth 5Y-2.81%
NGVT Yearly Profit, Operating, Gross MarginsNGVT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

More info and screens

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so NGVT is still creating some value.
The number of shares outstanding for NGVT has been increased compared to 1 year ago.
NGVT has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, NGVT has a worse debt to assets ratio.
NGVT Yearly Shares OutstandingNGVT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
NGVT Yearly Total Debt VS Total AssetsNGVT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 2.17 indicates that NGVT is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.17, NGVT is in line with its industry, outperforming 57.65% of the companies in the same industry.
NGVT has a debt to FCF ratio of 14.65. This is a negative value and a sign of low solvency as NGVT would need 14.65 years to pay back of all of its debts.
NGVT has a Debt to FCF ratio of 14.65. This is comparable to the rest of the industry: NGVT outperforms 57.65% of its industry peers.
NGVT has a Debt/Equity ratio of 5.68. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of NGVT (5.68) is worse than 91.76% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.68
Debt/FCF 14.65
Altman-Z 2.17
ROIC/WACC1.45
WACC8.64%
NGVT Yearly LT Debt VS Equity VS FCFNGVT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

A Current Ratio of 2.00 indicates that NGVT has no problem at all paying its short term obligations.
With a Current ratio value of 2.00, NGVT perfoms like the industry average, outperforming 55.29% of the companies in the same industry.
NGVT has a Quick Ratio of 1.08. This is a normal value and indicates that NGVT is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of NGVT (1.08) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2
Quick Ratio 1.08
NGVT Yearly Current Assets VS Current LiabilitesNGVT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 20.90% over the past year.
Measured over the past years, NGVT shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.12% on average per year.
NGVT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -17.64%.
Measured over the past years, NGVT shows a small growth in Revenue. The Revenue has been growing by 1.70% on average per year.
EPS 1Y (TTM)20.9%
EPS 3Y-11.81%
EPS 5Y-6.12%
EPS Q2Q%90.38%
Revenue 1Y (TTM)-17.64%
Revenue growth 3Y0.36%
Revenue growth 5Y1.7%
Sales Q2Q%-16.5%

3.2 Future

The Earnings Per Share is expected to grow by 16.97% on average over the next years. This is quite good.
Based on estimates for the next years, NGVT will show a small growth in Revenue. The Revenue will grow by 1.17% on average per year.
EPS Next Y21.09%
EPS Next 2Y18.61%
EPS Next 3Y16.97%
EPS Next 5YN/A
Revenue Next Year-5.83%
Revenue Next 2Y-0.73%
Revenue Next 3Y1.17%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
NGVT Yearly Revenue VS EstimatesNGVT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
NGVT Yearly EPS VS EstimatesNGVT Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 10.17, which indicates a very decent valuation of NGVT.
Based on the Price/Earnings ratio, NGVT is valued cheaper than 85.88% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.03, NGVT is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 8.18, the valuation of NGVT can be described as reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of NGVT indicates a rather cheap valuation: NGVT is cheaper than 84.71% of the companies listed in the same industry.
NGVT is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.94, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 10.17
Fwd PE 8.18
NGVT Price Earnings VS Forward Price EarningsNGVT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NGVT is valued a bit cheaper than 75.29% of the companies in the same industry.
75.29% of the companies in the same industry are more expensive than NGVT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 15.78
EV/EBITDA 7.25
NGVT Per share dataNGVT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
NGVT's earnings are expected to grow with 16.97% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.48
PEG (5Y)N/A
EPS Next 2Y18.61%
EPS Next 3Y16.97%

More info and screens

0

5. Dividend

5.1 Amount

NGVT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INGEVITY CORP

NYSE:NGVT (5/22/2025, 2:34:05 PM)

41.19

+0.13 (+0.32%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)05-05 2025-05-05/amc
Earnings (Next)07-29 2025-07-29/amc
Inst Owners103.53%
Inst Owner Change-1.83%
Ins Owners0.66%
Ins Owner Change24.61%
Market Cap1.50B
Analysts82
Price Target50.75 (23.21%)
Short Float %3.71%
Short Ratio4.54
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)117.25%
Min EPS beat(2)31.61%
Max EPS beat(2)202.89%
EPS beat(4)3
Avg EPS beat(4)62.07%
Min EPS beat(4)-6.05%
Max EPS beat(4)202.89%
EPS beat(8)6
Avg EPS beat(8)64.28%
EPS beat(12)8
Avg EPS beat(12)41.57%
EPS beat(16)11
Avg EPS beat(16)35.74%
Revenue beat(2)0
Avg Revenue beat(2)-4.11%
Min Revenue beat(2)-5.75%
Max Revenue beat(2)-2.47%
Revenue beat(4)0
Avg Revenue beat(4)-4.53%
Min Revenue beat(4)-6.04%
Max Revenue beat(4)-2.47%
Revenue beat(8)2
Avg Revenue beat(8)-1.58%
Revenue beat(12)4
Avg Revenue beat(12)-0.92%
Revenue beat(16)8
Avg Revenue beat(16)1.42%
PT rev (1m)-14.96%
PT rev (3m)-8.29%
EPS NQ rev (1m)-8.59%
EPS NQ rev (3m)-12.85%
EPS NY rev (1m)-4.39%
EPS NY rev (3m)-0.58%
Revenue NQ rev (1m)0.17%
Revenue NQ rev (3m)-7.26%
Revenue NY rev (1m)-2.65%
Revenue NY rev (3m)-8.06%
Valuation
Industry RankSector Rank
PE 10.17
Fwd PE 8.18
P/S 1.11
P/FCF 15.78
P/OCF 9.04
P/B 6.4
P/tB N/A
EV/EBITDA 7.25
EPS(TTM)4.05
EY9.83%
EPS(NY)5.04
Fwd EY12.23%
FCF(TTM)2.61
FCFY6.34%
OCF(TTM)4.56
OCFY11.07%
SpS37.06
BVpS6.44
TBVpS-6.12
PEG (NY)0.48
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.21%
ROE -150.81%
ROCE 15.9%
ROIC 12.56%
ROICexc 13.08%
ROICexgc 17.82%
OM 21.09%
PM (TTM) N/A
GM 34.69%
FCFM 7.04%
ROA(3y)-4.58%
ROA(5y)-0.24%
ROE(3y)-63.66%
ROE(5y)-29.04%
ROIC(3y)10.65%
ROIC(5y)10.84%
ROICexc(3y)11.07%
ROICexc(5y)11.72%
ROICexgc(3y)17.77%
ROICexgc(5y)19.74%
ROCE(3y)13.49%
ROCE(5y)13.72%
ROICexcg growth 3Y-8.19%
ROICexcg growth 5Y-5.86%
ROICexc growth 3Y-1.67%
ROICexc growth 5Y-0.8%
OM growth 3Y-6.17%
OM growth 5Y-4.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.27%
GM growth 5Y-2.81%
F-Score5
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 5.68
Debt/FCF 14.65
Debt/EBITDA 3.43
Cap/Depr 68.53%
Cap/Sales 5.26%
Interest Coverage 3.43
Cash Conversion 42.77%
Profit Quality N/A
Current Ratio 2
Quick Ratio 1.08
Altman-Z 2.17
F-Score5
WACC8.64%
ROIC/WACC1.45
Cap/Depr(3y)97.35%
Cap/Depr(5y)93.69%
Cap/Sales(3y)6.85%
Cap/Sales(5y)6.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.9%
EPS 3Y-11.81%
EPS 5Y-6.12%
EPS Q2Q%90.38%
EPS Next Y21.09%
EPS Next 2Y18.61%
EPS Next 3Y16.97%
EPS Next 5YN/A
Revenue 1Y (TTM)-17.64%
Revenue growth 3Y0.36%
Revenue growth 5Y1.7%
Sales Q2Q%-16.5%
Revenue Next Year-5.83%
Revenue Next 2Y-0.73%
Revenue Next 3Y1.17%
Revenue Next 5YN/A
EBIT growth 1Y24.1%
EBIT growth 3Y-5.83%
EBIT growth 5Y-2.78%
EBIT Next Year61.44%
EBIT Next 3Y23.37%
EBIT Next 5YN/A
FCF growth 1Y-38.13%
FCF growth 3Y-35.4%
FCF growth 5Y-20.53%
OCF growth 1Y-43.5%
OCF growth 3Y-24%
OCF growth 5Y-14.15%